2021 ICD-10-CM Code P04.11

Newborn affected by maternal antineoplastic chemotherapy

Version 2021
Billable Code

Valid for Submission

P04.11 is a billable diagnosis code used to specify a medical diagnosis of newborn affected by maternal antineoplastic chemotherapy. The code P04.11 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.

The ICD-10-CM code P04.11 might also be used to specify conditions or terms like fetal or neonatal effect of placental or breast transfer of chemotherapeutic agent.

ICD-10:P04.11
Short Description:Newborn affected by maternal antineoplastic chemotherapy
Long Description:Newborn affected by maternal antineoplastic chemotherapy

Code Classification

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code P04.11 are found in the index:

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

Replacement Code

P0411 replaces the following previously assigned ICD-10 code(s):

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019